keyword
MENU ▼
Read by QxMD icon Read
search

Genexpert

keyword
https://www.readbyqxmd.com/read/28087170/clostridium-difficile-rates-in-asymptomatic-and-symptomatic-hospitalized-patients-using-nucleic-acid-testing
#1
Cynthia Truong, Lee F Schroeder, Rajiv Gaur, Victoria Emma Anikst, Ikuko Komo, Colleen Watters, Erin McCalley, Carole Kulik, David Pickham, Nancy J Lee, Niaz Banaei
BACKGROUND: The Clostridium difficile rate in symptomatic patients represents both those with C. difficile infection (CDI) and those with colonization. To predict the extent of CDI overdiagnosis, we compared the asymptomatic colonization rate to the symptomatic positivity rate in hospitalized patients using nucleic acid testing. METHODS: Between July 2014 and April 2015, formed stool samples were collected from asymptomatic patients after admission to 3 hospital wards at the Stanford Hospital...
January 3, 2017: Diagnostic Microbiology and Infectious Disease
https://www.readbyqxmd.com/read/28081227/diagnostic-accuracy-of-genexpert-mtb-rif-assay-in-comparison-to-conventional-drug-susceptibility-testing-method-for-the-diagnosis-of-multidrug-resistant-tuberculosis
#2
Pratikshya Pandey, Narayan Dutt Pant, Komal Raj Rijal, Bhawana Shrestha, Sirita Kattel, Megha Raj Banjara, Bhagwan Maharjan, Rajendra Kc
Xpert MTB/RIF assay is regarded as a great achievement of modern medicine for the rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB). The main purpose of this study was to determine the performance of Xpert MTB/RIF assay compared to conventional drug susceptibility testing (DST) method for the diagnosis of MDR-TB. A comparative cross sectional study was carried out at German-Nepal Tuberculosis Project, Kathmandu, Nepal, from April 2014 to September 2014. A total of 88 culture positive clinical samples (83 pulmonary and 5 extra-pulmonary) received during the study period were analyzed for detection of multidrug-resistant tuberculosis by both GeneXpert MTB/RIF assay and conventional DST method...
2017: PloS One
https://www.readbyqxmd.com/read/28073895/evaluation-of-genotypic-and-phenotypic-methods-to-detect-carbapenemase-production-in-gram-negative-bacilli
#3
Allison R McMullen, Melanie L Yarbrough, Meghan A Wallace, Angela Shupe, Carey-Ann D Burnham
BACKGROUND: Carbapenemase-producing gram-negative bacteria (CP-GNB) are an urgent and expanding public health threat. Rapid and accurate identification of these organisms facilitates infection prevention efforts in healthcare facilities. The objective of our study was to evaluate methods to detect and identify CP-GNB. METHODS: We examined 189 carbapenem-resistant GNB (CR-GNB), including Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii complex, using 3 different methods: 2 methods to screen isolates of GNB for carbapenemase production [the carbapenem inactivation method (CIM) and 2 chromogenic agars] and a molecular method (Cepheid GeneXpert Carba-R) to identify the mechanism of carbapenem resistance and the associated resistance genes (blaKPC, blaNDM, blaIMP, blaOXA-48-like, and blaVIM)...
January 10, 2017: Clinical Chemistry
https://www.readbyqxmd.com/read/28059955/diagnosis-of-opportunistic-infections-hiv-co-infections-tuberculosis
#4
Lesley Scott, Pedro da Silva, Catharina C Boehme, Wendy Stevens, Chris Gilpin
PURPOSE OF REVIEW: Tuberculosis (TB) incidence has declined ∼1.5% annually since 2000, but continued to affect 10.4 million individuals in 2015, with 1/3 remaining undiagnosed or underreported. The diagnosis of TB among those co-infected with HIV is challenging as TB remains the leading cause of death in such individuals. Accurate and rapid diagnosis of active TB will avert mortality in both adults and children, reduce transmission, and assist in timeous decisions for antiretroviral therapy initiation...
January 5, 2017: Current Opinion in HIV and AIDS
https://www.readbyqxmd.com/read/28043602/screening-new-tuberculosis-patients-in-mali-for-rifampicin-resistance-at-2months
#5
Bassirou Diarra, Aissata B Cissé, Ousmane Kodio, Moumine Sanogo, Bocar Baya, Antieme C G Togo, Amadou Somboro, Mohamed Tolofoudié, Boureima Degoga, Marie Laure Keita, Fatimata Diallo, Natacha Nguiakam, Gagni Coulibaly, Sidy Bane, Yeya Dit Sadio Sarro, Seydou Doumbia, Robert Leo Murphy, Souleymane Diallo, Bouke C Dejong
OBJECTIVE/BACKGROUND: The recent call for universal drug susceptibility testing (DST) for all tuberculosis (TB) patients will be difficult to meet in settings where Xpert rollout is limited, such as low prevalence of HIV and Multi-drug Resistant Tuberculosis (MDR) settings. As recommended by World Health Organization (WHO) guidelines, the success of TB treatment is measured by Ziehl-Neelsen (ZN) microscopy or auramine-rhodamine fluorescent microscopy (FM) on sputum, in which conversion to negative smear at 2months (M) is an important predictor of treatment success, defined as a negative smear at 5M...
December 2016: International Journal of Mycobacteriology
https://www.readbyqxmd.com/read/28043548/discordance-between-genexpert-assay-and-conventional-drug-susceptibility-testing-in-detecting-rifampicin-resistant-tuberculosis-a-perspective-of-the-line-probe-assay
#6
Ruqaya M Ali, Ahmed A Alsudani
BACKGROUND: Early detection for tuberculosis (TB) and rifampicin-resistant TB (RRTB) is crucial for proper control of this disease. WHO recommended the use of the GeneXpert assay at district level to cover these two public health demands? A study evaluated the diagnostic impact of the GeneXpert assay in detecting TB and RRTB. Odd results were observed in this study in the form of discordance between the GeneXpert assay and the conventional culture and drug-susceptibility testing (DST)...
December 2016: International Journal of Mycobacteriology
https://www.readbyqxmd.com/read/28043540/nationwide-hiv-mdr-tb-survey-in-japan-and-collaborative-study-in-the-philippines
#7
Toshio Hattori, Nobuyuki Kobayashi, Hideaki Nagai, Haorile Chagan-Yasutan, Elizabeth Telan, Marietta B Solante
BACKGROUND: Although the prevalence of pulmonary tuberculosis (TB) and HIV infection in Japan is low, careful monitoring of these two diseases is necessary. We conducted a nationwide survey on multidrug resistant (MDR)-TB (2011-2013) and HIV-TB (2007-2014) to understand the mode of prevention and the effect of therapy. A study on MDR-TB and HIV in San Lazaro Hospital (SLH) in the Philippines was also conducted. These studies introduced an international collaborative study against the global epidemics of HIV-TB/MDR-TB...
December 2016: International Journal of Mycobacteriology
https://www.readbyqxmd.com/read/28043528/childhood-tuberculosis-in-qatar
#8
Jay P N Singh, Reem Mohammed, Thanveer Thayyullathil, Abdullatif Al-Khal, Zubaida Al-Suwaidi
Childhood tuberculosis (TB) has been long neglected but has gained attention in recent years. In 2012, the World Health Organization annual report included an estimate for childhood TB for the first time, and in the following year, the TB Alliance received a grant from UNITAID (International Drug Purchase Facility) to develop pediatric TB formulations. Qatar is a low-incidence country. In this observational study, laboratory-confirmed cases of TB were analyzed from 2013 to 2015 and included patients aged ⩽14years...
December 2016: International Journal of Mycobacteriology
https://www.readbyqxmd.com/read/28043515/evaluation-of-rifampicin-resistance-and-81-bp-rifampicin-resistant-determinant-region-of-rpob-gene-mutations-of-mycobacterium-tuberculosis-detected-with-xpertmtb-rif-in-cross-river-state-nigeria
#9
Ernest A Ochang, Ubong A Udoh, Ubleni E Emanghe, Gerald O Tiku, Jonah B Offor, Micheal Odo, Emmanuel Nkombe, Oju E Owuna, Sunday M Obeten, Martin M Meremikwu
OBJECTIVE/BACKGROUND: World Health Organization tuberculosis (TB) indices from 2014 to 2016 showed that Nigeria had the 6th highest prevalence, 4th highest incidence, and the highest mortality rate globally. In efforts to improve TB care, the XpertMTB/Rif (GeneXpert) technology, Cepheid, Sunnyvale, California, USA, which has revolutionized TB detection with concomitant rifampicin-resistance molecular detection, was introduced in Cross River State, South-South Nigeria, in 2014. The GeneXpert uses molecular beacons to detect five overlapping 81-bp regions in the rpoB gene known as the Rifampicin Resistant Determinant Region (RRDR)...
December 2016: International Journal of Mycobacteriology
https://www.readbyqxmd.com/read/28004323/rapid-mrsa-pcr-on-respiratory-specimens-from-ventilated-patients-with-suspected-pneumonia-a-tool-to-facilitate-antimicrobial-stewardship
#10
S E Trevino, M A Pence, J Marschall, M H Kollef, H M Babcock, C-A D Burnham
Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of pneumonia in ventilated patients. Our objective was to evaluate the GeneXpert MRSA/SA SSTI Assay (Xpert MRSA/SA) (Cepheid, Sunnyvale, CA) for use in lower respiratory tract (LRT) specimens for rapid MRSA detection and to determine the potentially saved antibiotic-days if a culture-based identification method was replaced by this assay. Remnant LRT samples from ventilated patients submitted to the microbiology laboratory for routine culture were tested using conventional culture and Xpert MRSA/SA...
December 21, 2016: European Journal of Clinical Microbiology & Infectious Diseases
https://www.readbyqxmd.com/read/28003349/assessment-and-optimization-of-the-genexpert-diagnostic-platform-for-detection-of-ebola-virus-rna-in-seminal-fluid
#11
James Pettitt, Elizabeth Higgs, Mosoka Fallah, Martha Nason, Eric Stavale, Jonathan Marchand, Cavan Reilly, Kenneth Jensen, Bonnie Dighero-Kemp, Kaylie Tuznik, James Logue, Fatorma Bolay, Lisa Hensley
Recent studies have suggested that Ebola virus (EBOV) RNA potentially present in the semen of a large number of survivors of Ebola virus disease (EVD) in Western Africa may contribute to sexual transmission of EVD and generate new clusters of cases in regions previously declared EBOV free. These findings drive the immediate need for a reliable, rapid, user-friendly assay for detection of EBOV RNA in semen that is deployable to multiple sites across Western Africa. In this study, we optimized the Xpert EBOV assay for semen samples by adding dithiothreitol...
December 21, 2016: Journal of Infectious Diseases
https://www.readbyqxmd.com/read/27994107/evaluation-of-the-genexpert-for-human-monkeypox-diagnosis
#12
Daniel Li, Kimberly Wilkins, Andrea M McCollum, Lynda Osadebe, Joelle Kabamba, Beatrice Nguete, Toutou Likafi, Marcel Pie Balilo, Robert Shongo Lushima, Jean Malekani, Inger K Damon, Michael C L Vickery, Elisabeth Pukuta, Frida Nkawa, Stomy Karhemere, Jean-Jacques Muyembe Tamfum, Emile Wemakoy Okitolonda, Yu Li, Mary G Reynolds
Monkeypox virus (MPXV), a zoonotic orthopoxvirus (OPX), is endemic in the Democratic Republic of Congo (DRC). Currently, diagnostic assays for human monkeypox (MPX) focus on real-time quantitative polymerase chain reaction (qPCR) assays, which are typically performed in sophisticated laboratory settings. Herein, we evaluate the accuracy and utility of a multiplex MPXV assay using the GeneXpert platform, a portable rapid diagnostic device that may serve as a point-of-care test to diagnose infections in endemic areas...
December 19, 2016: American Journal of Tropical Medicine and Hygiene
https://www.readbyqxmd.com/read/27992495/options-to-expand-hiv-viral-load-testing-in-south-africa-evaluation-of-the-genexpert%C3%A2-hiv-1-viral-load-assay
#13
Natasha Gous, Lesley Scott, Leigh Berrie, Wendy Stevens
BACKGROUND: Expansion of HIV viral load (VL) testing services are required to meet increased targets for monitoring patients on antiretroviral treatment. South Africa currently tests >4million VLs per annum in 16 highly centralised, automated high-throughput laboratories. The Xpert HIV-1 VL assay (Cepheid) was evaluated against in-country predicates, the Roche Cobas Taqmanv2 and Abbott HIV-1RT, to investigate options for expanding VL testing using GeneXpert's random access, polyvalent capabilities and already established footprint in South Africa with the Xpert MTB/RIF assay (207 sites)...
2016: PloS One
https://www.readbyqxmd.com/read/27932614/validation-of-the-cepheid-genexpert-for-detecting-ebola-virus-in-semen
#14
Amy James Loftis, Saturday Quellie, Kelly Chason, Emmanuel Sumo, Mason Toukolon, Yonnie Otieno, Heinzfried Ellerbrok, Marcia M Hobbs, David Hoover, Karine Dube, David A Wohl, William A Fischer
BACKGROUND: Ebola virus (EBOV) RNA persistence in semen, reported sexual transmission, and sporadic clusters at the end of the 2013-2016 epidemic have prompted recommendations that male survivors refrain from unprotected sex unless their semen is confirmed to be EBOV-free. However, there is no fully validated assay for EBOV detection in fluids other than blood. METHODS: The Cepheid Xpert Ebola assay for EBOV RNA detection was validated for whole semen and blood using samples obtained from uninfected donors and spiked with inactivated EBOV...
December 8, 2016: Journal of Infectious Diseases
https://www.readbyqxmd.com/read/27913043/evaluation-of-the-genexpert-mtb-rif-assay-on-extrapulmonary-and-respiratory-samples-other-than%C3%A2-sputum-a-low-burden-country-experience
#15
Sushil Pandey, Jacob Congdon, Bradley McInnes, Alina Pop, Christopher Coulter
The aim of this study was to assess the performance of the GeneXpert MTB/RIF assay on extrapulmonary (EP) and respiratory (non-sputum) clinical samples of patients suspected of having tuberculosis (TB) from Queensland, Australia. A total of 269 EP and respiratory (non-sputum) clinical samples collected from Qld patients who were suspected of having TB were subjected to the GeneXpert MTB/RIF analysis, Ziehl-Neelsen (ZN) staining, Mycobacterium tuberculosis (MTB) culture and drug susceptibility testing. Phenotypic and genotypic data were compared...
January 2017: Pathology
https://www.readbyqxmd.com/read/27874159/evaluation-of-genexpert-mtb-rif-for-detection-of-mycobacterium-tuberculosis-complex-and-rpo-b-gene-in-respiratory-and-non-respiratory-clinical-specimens-at-a-tertiary-care-teaching-hospital-in-saudi-arabia
#16
Ali M Somily, Mazin A Barry, Hanan A Habib, Fawzia E Alotaibi, Fahad A Al-Zamil, Mohammed A Khan, Mohammed S Sarwar, Nawab D Bakhash, Abdulkarim A Alrabiaah, Zahid A Shakoor, Abiola C Senok
To assess the performance of Xpert MTB/RIF, an automated molecular test for Mycobacterium tuberculosis (MTB) and resistance to rifampin (RIF), against smear microscopy and culture method for diagnosis of MTB infection. Methods: This is a retrospective analysis of 103 respiratory and 137 non-respiratory patient specimens suspected of tuberculosis at King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia performed between April 2014 and March 2015. Each sample underwent smear microscopy, mycobacterial culture, and GeneXpert MTB/RIF test...
December 2016: Saudi Medical Journal
https://www.readbyqxmd.com/read/27865383/analytical-and-clinical-performance-characteristics-of-the-abbott-realtime-mtb-rif-inh-resistance-an-assay-for-the-detection-of-rifampicin-and-isoniazid-resistant-mycobacterium-tuberculosis-in-pulmonary-specimens
#17
Joshua Kostera, Gregor Leckie, Ning Tang, John Lampinen, Magdalena Szostak, Klara Abravaya, Hong Wang
Clinical management of drug-resistant tuberculosis patients continues to present significant challenges to global health. To tackle these challenges, the Abbott RealTime MTB RIF/INH Resistance assay was developed to accelerate the diagnosis of rifampicin and/or isoniazid resistant tuberculosis to within a day. This article summarizes the performance of the Abbott RealTime MTB RIF/INH Resistance assay; including reliability, analytical sensitivity, and clinical sensitivity/specificity as compared to Cepheid GeneXpert MTB/RIF version 1...
December 2016: Tuberculosis
https://www.readbyqxmd.com/read/27847371/sensitive-detection-of-francisella-tularensis-directly-from-whole-blood-by-use-of-the-genexpert-system
#18
Padmapriya P Banada, Srinidhi Deshpande, Soumitesh Chakravorty, Riccardo Russo, James Occi, Gabriel Meister, Kelly J Jones, Carl H Gelhaus, Michelle W Valderas, Martin Jones, Nancy Connell, David Alland
Francisella tularensis is a potential bioterrorism agent that is highly infectious at very low doses. Diagnosis of tularemia by blood culture and nucleic acid-based diagnostic tests is insufficiently sensitive. Here, we demonstrate a highly sensitive F. tularensis assay that incorporates sample processing and detection into a single cartridge suitable for point-of-care detection. The assay limit of detection (LOD) and dynamic range were determined in a filter-based cartridge run on the GeneXpert system. F. tularensis DNA in buffer or CFU of F...
January 2017: Journal of Clinical Microbiology
https://www.readbyqxmd.com/read/27847010/nontuberculous-mycobacteria-in-fistula-in-ano-a-new-finding-and-its-implications
#19
Pankaj Garg
OBJECTIVE/BACKGROUND: Nontuberculous mycobacteria (NTM) are not known to be associated with fistula-in-ano. NTM was detected in three fistula-in-ano patients in our series. In this study, related data was reviewed to find the mycobacterial disease in patients in our database. METHODS: In this study, 311 consecutive fistula-in-ano patients operated over 2years were analyzed. The histopathology of anal fistula tract epithelial lining of every operated patient was analyzed and other tests (real-time-polymerase chain reaction [RT-PCR], GeneXpert, and mycobacterial culture) were conducted in patients with high index of suspicion of having mycobacterial disease...
September 2016: International Journal of Mycobacteriology
https://www.readbyqxmd.com/read/27846818/asymptomatic-and-yet-c-difficile-toxin-positive-prevalence-and-risk-factors-of-carriers-of-toxigenic-clostridium-difficile-among-geriatric-in-patients
#20
Klaus Nissle, Daniel Kopf, Alexander Rösler
BACKGROUND: Clostridium difficile infections (CDI) are the most frequent cause of diarrhoea in hospitals. Geriatric patients are more often affected by the condition, by a relapse and complications. Therefore, a crucial question is how often colonization with toxigenic Clostridium difficile strains occurs in elderly patients without diarrhoea and whether there is a "risk pattern" of colonized patients that can be defined by geriatric assessment. Furthermore, the probability for those asymptomatic carriers to develop a symptomatic infection over time has not been sufficiently explored...
November 15, 2016: BMC Geriatrics
keyword
keyword
53912
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"